What's in Aya Sabry Mohamed Mohamed's pipeline?

Aya Sabry Mohamed Mohamed has 3 drugs in our index: 3 marketed, 0 filed, 0 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Aya Sabry Mohamed Mohamed's portfolio?

Top competitors by shared drug class: B.P. Koirala Institute of Health Sciences, Stanley Dudrick's Memorial Hospital.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/aya-sabry-mohamed-mohamed.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Aya Sabry Mohamed Mohamed — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Aya Sabry Mohamed Mohamed pipeline: 3 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

3 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
Toxogonin	Toxogonin	marketed		Acetylcholinesterase	Other
Sodium Bicarbonate Powder and ondansetron	Sodium Bicarbonate Powder and ondansetron	marketed	Antacid and antiemetic combination	5-HT3 receptor (ondansetron); non-specific acid neutralization (sodium bicarbonate)	Gastroenterology
Lipid Emulsion, Intravenous	Lipid Emulsion, Intravenous	marketed	Parenteral nutrition supplement		Nutrition support / Critical care

Therapeutic area mix

Gastroenterology · 1
Nutrition support / Critical care · 1
Other · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

B.P. Koirala Institute of Health Sciences · 1 shared drug class
Stanley Dudrick's Memorial Hospital · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Aya Sabry Mohamed Mohamed:

Cite this brief

Drug Landscape (2026). Aya Sabry Mohamed Mohamed — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/aya-sabry-mohamed-mohamed. Accessed 2026-05-17.